Coronavirus and TCM, Part 3: Scientific Research and Clinical Evidence of Chinese Herbs featuring Dr. John Chen
Co-sponsored by Pacific College and Lhasa OMS
TCM has been used with great success to combat coronavirus (Covid-19) in China; however, its influence was barely palpable in the Western countries. Even as the Covid-19 pandemic reached its peak around the world, many TCM practitioners were forced to close their clinics because their services were “non-essential.” This pattern of disharmony occurs in part because we as a profession have not communicated effectively with the public and the Western medicine healthcare practitioners. We must go beyond the philosophy of yin and yang and present the science of TCM. We must learn the pharmacology of herbal medicine and present the clinical evidence of herbal treatment. These are challenges we must overcome to earn the respect and credibility to become mainstream healthcare practitioners.
- Virology and pathophysiology of Covid-19
- Pharmacological research of Chinese herbs
- Clinical studies of Chinese herbal formulas
- Safety concerns of Chinese herbs: side effects, adverse reactions, caution, contraindications, herb-drug interactions, etc.
John Chen, PharmD, PhD, OMD, LAc
Medical Consultant, Evergreen Herbs & Medical Supplies
Dr. John Chen’s participation in the family tradition has led him to become a recognized authority in both western pharmacology and Chinese Herbal Medicine. He has taught herbology and pharmacology at:
- University of Southern California School of Pharmacy
- University of California, San Francisco School of Pharmacy
- Pacific College of Health and Science, San Diego, California
- Emperor’s College of Traditional Oriental Medicine, Santa Monica, California
- Yo San University of Traditional Chinese Medicine, Los Angeles, California
- Bastyr University, Seattle, Washington
- Five Branches Institute, San Jose, California
- Oregon College of Oriental Medicine, Portland, Oregon
- Academy of Oriental Medicine at Austin, Texas
- Southern California University of Health Sciences, Whittier, California
- American College of Traditional Chinese Medicine, San Francisco, California
He has also given seminars on herb-drug interactions for regional and national associations and organizations, including:
- The American Association of Acupuncture and Oriental Medicine
- The California State Oriental Medical Association
- The Queen’s Physician Group of Hawaii
- The North Carolina Acupuncture Association
Dr. Chen is currently a member of the Herbal Medicine Committee for the American Association of Acupuncture and Oriental Medicine; he is an herbal consultant for the California State Oriental Medical Association and is on the review/editorial committee for American Herbal Pharmacopoeia, the University of Arizona Integrative Medicine Program, and the American Academy of Medical Acupuncture.
Dr. Chen has published numerous articles and several books. His most recently published works are Chinese Medical Herbology and Pharmacology (2003, AOM Press) and Chinese Herbal Formulas and Applications (2008, AOM Press) for which he was lead author.
“The effectiveness of treatment is of utmost concern to me, for each and every patient. The safety, quality, and potency of the herbs are crucial factors in determining treatment outcome. My goal is to make both Western and Oriental medical communities aware of herbal alternatives to drugs, and of the importance of identifying herb-drug interactions. I hope to see us eventually bridging the gap between Eastern and Western medicine by integrating use of herbs and related TCM modalities with modern technological medicine.”
Are you interested in becoming a certified acupuncture professional?
Visit the links below to explore our specialized acupuncture programs at a campus near you:
Featured Posts:
- Webinar: How the Coronavirus is Treated by TCM in China
- Covid19 – Class Cancellations Notification
- Secrets of Longevity: Herbs, Remedies and Elixirs
- COVID19 – Announcement from President Jack Miller
- Properties of Oriental Medicine Herbs